Establishment of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria and Solicitation of Nominations for Appointment to the Council Membership, 16684-16686 [2015-07235]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
16684
Federal Register / Vol. 80, No. 60 / Monday, March 30, 2015 / Notices
Program for Education and Training in
Pain Care.
The members of the ACICBL will
resume their discussion of the
legislatively mandated 15th Annual
Report to the Secretary of Health and
Human Services and Congress. The
Committee members will continue to
review, discuss, and make
recommendations for programs under
title VII, part D. The members will hear
presentations on allied health, podiatry,
chiropractic, pain care management, the
budget process, primary care workforce
reports, healthcare practice redesign,
interprofessional accreditation
standards, and performance
measurement.
Agenda: Healthcare practice redesign
initiatives, such as the Patient-Centered
Medical Home Model or the Planned
Care Model, are emerging approaches to
improve the quality of primary health
care delivery. These models are
comprehensive, multifaceted, and seek
to provide high-quality care and
continuity while involving patients,
communities, health care teams, and
policy makers. The members of the
ACICBL will review (a) current issues
related to healthcare practice redesign,
(b) the implications of practice redesign
on health professions education in
relation to title VII, part D programs,
and (c) accreditation standards for the
disciplines that have incorporated
interprofessional education into their
accreditation standards and the effect
this has had on practice. Committee
discussion questions include:
• How will changing the scope of
practice of health professionals affect
title VII, part D programming?
• What statutory changes are needed
to align with healthcare practice
redesign?
• What measures are needed for title
VII, part D programs to have an impact
on outcomes and quality?
The official agenda will be available
2 days prior to the meeting on the HRSA
Web site at: https://www.hrsa.gov/
advisorycommittees/bhpradvisory/
acicbl/. Agenda items are
subject to change as priorities dictate.
Public Comment: Requests to make
oral comments or provide written
comments to the ACICBL should be sent
to Dr. Joan Weiss, Designated Federal
Official, using the address and phone
number below. Individuals who plan to
participate on the conference call or
webinar should notify Dr. Weiss at least
3 days prior to the meeting, using the
address and phone number below.
Members of the public will have the
opportunity to provide comments.
Interested parties should refer to the
meeting subject as the HRSA Advisory
VerDate Sep<11>2014
19:57 Mar 27, 2015
Jkt 235001
Committee on Interdisciplinary,
Community-Based Linkages.
The conference call-in number is 877–
960–9066. The passcode is: 5919914.
The webinar link is: https://
hrsa.connectsolutions.com/
acicblapril22_23/.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the ACICBL should contact
Dr. Joan Weiss, Designated Federal
Official within the Bureau of Health
Workforce, Health Resources and
Services Administration, in one of three
ways: (1) Send a request to the following
address: Dr. Joan Weiss, Designated
Federal Official, Bureau of Health
Workforce, Health Resources and
Services Administration, Parklawn
Building, Room 12C–05, 5600 Fishers
Lane, Rockville, Maryland 20857; (2)
call (301) 443–0430; or (3) send an email
to jweiss@hrsa.gov.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–07154 Filed 3–27–15; 8:45 am]
BILLING CODE 4165–15–P
and the National Action Plan for
Combating Antibiotic-Resistant Bacteria
(Action Plan).
This notice also will serve to
announce that HHS is seeking
nominations of individuals who are
interested in being considered for
appointment to the Advisory Council.
Resumes or curricula vitae from
qualified individuals who wish to be
considered for appointment as a
member of the Advisory Council are
currently being accepted.
DATES: Nominations must be received
no later than close business April 29,
2015.
All nominations should be
sent to: Bruce Gellin, M.D., M.P.H.,
Deputy Assistant Secretary for Health;
Office of the Assistant Secretary for
Health; Department of Health and
Human Services; 200 Independence
Avenue SW., Room 715H; Washington,
DC 20201. Nomination materials,
including attachments, also may be
submitted electronically to CARB@
hhs.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Establishment of the Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria and
Solicitation of Nominations for
Appointment to the Council
Membership
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
Authority: Executive Order 13676,
dated September 18, 2014, authorizes
establishment of the Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria (Advisory
Council). The Advisory Council will be
governed by provisions of the Federal
Advisory Committee Act, Public Law
92–463, as amended (5 U.S.C. App.),
which sets forth standards for the
formation and use of federal advisory
committees.
SUMMARY: The U.S. Department of
Health and Human Services (HHS)
announces establishment of the
Advisory Council. The Advisory
Council will provide advice,
information, and recommendations to
the Secretary regarding programs and
policies intended to support and
evaluate the implementation of
Executive Order 13676, including the
National Strategy for Combating
Antibiotic-Resistant Bacteria (Strategy)
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Bruce Gellin, M.D., M.P.H., Deputy
Assistant Secretary for Health; Office of
the Assistant Secretary for Health;
Department of Health and Human
Services; Telephone: (202) 260–6638;
Fax: (202) 690–4631; Email address:
CARB@hhs.gov. The Advisory Council
charter may be accessed online at
https://www.hhs.gov/ash/carb. The
charter includes detailed information
about the Advisory Council’s purpose,
function, and structure.
SUPPLEMENTARY INFORMATION: The rise of
antibiotic-resistant bacteria represents a
serious threat to public health and the
economy. Detecting, preventing, and
controlling antibiotic resistance requires
a strategic, coordinated, and sustained
effort. The federal government will work
domestically and internationally to
detect, prevent, and control illness and
death related to antibiotic-resistant
infections by implementing measures
that reduce the emergence and spread of
antibiotic-resistant bacteria and help
ensure the continued availability of
effective therapeutics for the treatment
of bacterial infections.
Under Executive Order 13676, the
Secretary of Health and Human Services
(the Secretary) is directed to establish
the Advisory Council in consultation
with the Secretaries of Defense and
Agriculture. The Advisory Council will
provide advice and recommendations to
the Secretary regarding programs and
policies to support and evaluate the
implementation of Executive Order
13676, including the National Strategy
E:\FR\FM\30MRN1.SGM
30MRN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 60 / Monday, March 30, 2015 / Notices
for Combating Antibiotic-Resistant
Bacteria (Strategy) and the National
Action Plan for Combating AntibioticResistant Bacteria (Action Plan). On
March 24, 2015, the Secretary approved
for the Advisory Council to be
established. The charter for the
Advisory Council was filed with the
appropriate Congressional committees
and the Library of Congress on the same
date. The Advisory Council has been
established as a non-discretionary
federal advisory committee.
Objectives and Scope of Activities.
The Advisory Council will provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to support and evaluate the
implementation of Executive Order
13676, including the Strategy and
Action Plan. The Advisory Council will
function solely for advisory purposes.
Membership and Designation. The
Advisory Council will consist of not
more than 30 members, including the
voting and non-voting members and
Chair and Vice Chair. The members will
be appointed or designated by the
Secretary, who will designate the Chair
and Vice Chair from among the voting
members of the Advisory Council.
Voting Members. There will be public
voting members selected from
individuals who are engaged in research
on, or implementation of, interventions
regarding efforts to preserve the
effectiveness of antibiotics by
optimizing their use; advance research
to develop improved methods for
combating antibiotic resistance and
conducting antibiotic stewardship;
strengthen surveillance of antibioticresistant bacterial infections; prevent
the transmission of antibiotic-resistant
bacterial infections; advance the
development of rapid point-of-care and
agricultural diagnostics; further research
on new treatments for bacterial
infections; develop alternatives to
antibiotics for agricultural purposes;
maximize the dissemination of up-todate information on the appropriate and
proper use of antibiotics to the general
public and human and animal
healthcare providers; and improve
international coordination of efforts to
combat antibiotic resistance.
The public voting members will
represent balanced points of view from
human biomedical, public health, and
agricultural fields to include
surveillance of antibiotic-resistant
infections, prevention and/or
interruptions of the spread of antibioticresistant threats, or development of
rapid diagnostics and novel treatments.
The public voting members may be
physicians, veterinarians,
VerDate Sep<11>2014
19:57 Mar 27, 2015
Jkt 235001
epidemiologists, microbiologists, or
other health care professionals (e.g.,
nurses, pharmacists, others); individuals
who have expertise and experience as
consumer or patient advocates
concerned with antibiotic resistance, or
in the fields of agriculture and
pharmaceuticals; and they also may be
from State or local health agencies or
public health organizations. All public
voting members will be classified as
special Government employees (SGEs).
Ex-officio Members (non-voting). The
Advisory Council will include members
selected to represent various federal
agencies, including HHS, DoD, and
USDA, that are involved in the
development, testing, licensing,
production, procurement, distribution,
and/or use of antibiotics and/or
antibiotic research. The federal exofficio members shall possess the
knowledge, skills, experience, and
expertise necessary to generate informed
and intelligent recommendations with
respect to the issues mandated by
Executive Order 13676. Federal agencies
will be invited to participate as nonvoting ex-officio members of the
Advisory Council, as it is deemed
necessary by the Secretary, in
consultation with the Secretaries of
Defense and Agriculture, to accomplish
the mission the Advisory Council.
Liaison Representatives (non-voting).
The Advisory Council structure also
may include non-voting liaison
representatives from organizations and/
or interest groups that have involvement
in the development, testing, licensing,
production, procurement, distribution,
and/or use of antibiotics and/or
antibiotic research. Organizations will
be invited to participate as non-voting
liaison representatives as it is deemed
necessary by the Secretary or designee
to accomplish the established mission of
the Advisory Council.
The public voting and non-voting
liaison representative members will be
appointed to serve for overlapping terms
of up to four years. The Chair and Vice
Chair will be appointed to serve for
three years, unless otherwise specified.
The public voting members are
authorized to receive per diem and
reimbursement for travel expenses when
attending meetings of the Advisory
Council, as authorized by Section 5703,
Title 5 U.S.C., as amended for persons
employed intermittently in Government
service. Individuals who are appointed
to serve as non-voting liaison
representative members also may be
allowed to receive per diem and
reimbursement for any applicable
expenses for travel that is performed to
attend meetings of the Advisory Council
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
16685
in accordance with Federal travel
regulations.
Estimated Number and Frequency of
Meetings. The Advisory Council will
meet, at a minimum, two times per
fiscal year depending on the availability
of funds. Meetings will be open to the
public, except as determined otherwise
by the Secretary or other official to
whom the authority has been delegated
in accordance with guidelines under
Government in the Sunshine Act, 5
U.S.C. 552b(c).
Nominations: Nominations, including
self-nominations, of individuals who
have the specified expertise and
knowledge will be considered for
appointment as public voting and/or
non-voting members of the Advisory
Council. A nomination should include,
at a minimum, the following for each
nominee: (1) A letter of nomination that
clearly states the name and affiliation of
the nominee, the basis for the
nomination (i.e., the desired member
category and specific attributes which
qualify the nominee to be considered for
appointment as a public voting and/or
non-voting member of the Advisory
Council), and a statement from the
nominee (including designated
representatives of organizations and/or
interest groups) that indicates that the
individual is willing to serve as a
member of the Advisory Council, if
selected; (2) the nominator’s name,
address, and daytime telephone
number, and the address, telephone
number, and email address of the
individual being nominated; and (3) a
current copy of the nominee’s
curriculum vitae or resume, which
should be limited to no more than 10
pages.
Every effort will be made to ensure
that the Advisory Council is a diverse
group of individuals with representation
from various geographic locations, racial
and ethnic minorities, all genders, and
persons living with disabilities.
Individuals being considered for
appointment as public voting members
will be required to complete and submit
a report of their financial holdings. An
ethics review must be conducted to
ensure that individuals appointed as
public voting members of the Advisory
Council are not involved in any activity
that may pose a potential conflict of
interest for the official duties that are to
be performed. This is a federal ethics
requirement that must be satisfied upon
entering the position and annually
throughout the established term of
appointment on the Advisory Council.
E:\FR\FM\30MRN1.SGM
30MRN1
16686
Federal Register / Vol. 80, No. 60 / Monday, March 30, 2015 / Notices
Dated: March 24, 2015.
Sylvia M. Burwell,
Secretary of Health and Human Services.
[FR Doc. 2015–07235 Filed 3–27–15; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–29, CMS–10221
and CMS–R–263]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ACTION:
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by April 29, 2015.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:57 Mar 27, 2015
Jkt 235001
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/Paperwork
ReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Verification of
Clinic Data—Rural Health Clinic Form
and Supporting Regulations; Use: The
form is utilized as an application to be
completed by suppliers of Rural Health
Clinic (RHC) services requesting
participation in the Medicare program.
This form initiates the process of
obtaining a decision as to whether the
conditions for certification are met as a
supplier of RHC services. It also
promotes data reduction or introduction
to and retrieval from the Automated
Survey Process Environment (ASPEN)
and related survey and certification
databases by the CMS Regional Offices.
Should any question arise regarding the
structure of the organization, this
information is readily available. Form
Number: CMS–29 (OMB control number
0938–0074); Frequency: Occasionally
(initially and then every six years);
Affected Public: Private Sector (Business
or other for-profit and Not-for-profit
institutions); Number of Respondents:
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
900; Total Annual Responses: 900; Total
Annual Hours: 150. (For policy
questions regarding this collection
´
contact Shonte Carter at 410–786–3532.)
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Site
Investigation for Independent
Diagnostic Testing Facilities (IDTFs);
Use: We enroll Independent Diagnostic
Testing Facilities (IDTFs) into the
Medicare program via a uniform
application, the CMS 855B.
Implementation of enhanced procedures
for verifying the enrollment information
has improved the enrollment process as
well as identified and prevented
fraudulent IDTFs from entering the
Medicare program. As part of this
process, verification of compliance with
IDTF performance standards is
necessary. The primary function of the
site investigation form for IDTFs is to
provide a standardized, uniform tool to
gather information from an IDTF that
tells us whether it meets certain
standards to be a IDTF (as found in 42
CFR 410.33(g)) and where it practices or
renders its services. The site
investigation form has been used in the
past to aid in verifying compliance with
the required performance standards
found in 42 CFR 410.33(g). No revisions
have been made to this form since the
last submission for OMB approval. Form
Number: CMS–10221 (OMB Control
Number: 0938–1029); Frequency:
Occasionally; Affected Public: Private
Sector (Business or other for-profits and
Not-for-profit institutions); Number of
Respondents: 900; Total Annual
Responses: 900; Total Annual Hours:
1,800. (For policy questions regarding
this collection contact Kim McPhillips
at 410–786–5374).
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Site
Investigation for Suppliers of Durable
Medical Equipment, Prosthetics,
Orthotics and Supplies (DMEPOS); Use:
We enroll suppliers of durable medical
equipment, prosthetics, orthotics, and
supplies (DMEPOS) into the Medicare
program via a uniform application, the
CMS 855S. Implementation of enhanced
procedures for verifying the enrollment
information has improved the
enrollment process as well as identified
and prevented fraudulent DMEPOS
suppliers from entering the Medicare
program. As part of this process,
verification of compliance with supplier
standards is necessary. The primary
function of the site investigation form is
to provide a standardized, uniform tool
to gather information from a DMEPOS
E:\FR\FM\30MRN1.SGM
30MRN1
]]>Agencies
[Federal Register Volume 80, Number 60 (Monday, March 30, 2015)]
[Notices]
[Pages 16684-16686]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07235]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Establishment of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria and Solicitation of Nominations for
Appointment to the Council Membership
AGENCY: Office of the Secretary, Department of Health and Human
Services.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: Executive Order 13676, dated September 18, 2014,
authorizes establishment of the Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (Advisory Council). The
Advisory Council will be governed by provisions of the Federal Advisory
Committee Act, Public Law 92-463, as amended (5 U.S.C. App.), which
sets forth standards for the formation and use of federal advisory
committees.
SUMMARY: The U.S. Department of Health and Human Services (HHS)
announces establishment of the Advisory Council. The Advisory Council
will provide advice, information, and recommendations to the Secretary
regarding programs and policies intended to support and evaluate the
implementation of Executive Order 13676, including the National
Strategy for Combating Antibiotic-Resistant Bacteria (Strategy) and the
National Action Plan for Combating Antibiotic-Resistant Bacteria
(Action Plan).
This notice also will serve to announce that HHS is seeking
nominations of individuals who are interested in being considered for
appointment to the Advisory Council. Resumes or curricula vitae from
qualified individuals who wish to be considered for appointment as a
member of the Advisory Council are currently being accepted.
DATES: Nominations must be received no later than close business April
29, 2015.
ADDRESSES: All nominations should be sent to: Bruce Gellin, M.D.,
M.P.H., Deputy Assistant Secretary for Health; Office of the Assistant
Secretary for Health; Department of Health and Human Services; 200
Independence Avenue SW., Room 715H; Washington, DC 20201. Nomination
materials, including attachments, also may be submitted electronically
to CARB@hhs.gov.
FOR FURTHER INFORMATION CONTACT: Bruce Gellin, M.D., M.P.H., Deputy
Assistant Secretary for Health; Office of the Assistant Secretary for
Health; Department of Health and Human Services; Telephone: (202) 260-
6638; Fax: (202) 690-4631; Email address: CARB@hhs.gov. The Advisory
Council charter may be accessed online at https://www.hhs.gov/ash/carb.
The charter includes detailed information about the Advisory Council's
purpose, function, and structure.
SUPPLEMENTARY INFORMATION: The rise of antibiotic-resistant bacteria
represents a serious threat to public health and the economy.
Detecting, preventing, and controlling antibiotic resistance requires a
strategic, coordinated, and sustained effort. The federal government
will work domestically and internationally to detect, prevent, and
control illness and death related to antibiotic-resistant infections by
implementing measures that reduce the emergence and spread of
antibiotic-resistant bacteria and help ensure the continued
availability of effective therapeutics for the treatment of bacterial
infections.
Under Executive Order 13676, the Secretary of Health and Human
Services (the Secretary) is directed to establish the Advisory Council
in consultation with the Secretaries of Defense and Agriculture. The
Advisory Council will provide advice and recommendations to the
Secretary regarding programs and policies to support and evaluate the
implementation of Executive Order 13676, including the National
Strategy
[[Page 16685]]
for Combating Antibiotic-Resistant Bacteria (Strategy) and the National
Action Plan for Combating Antibiotic-Resistant Bacteria (Action Plan).
On March 24, 2015, the Secretary approved for the Advisory Council to
be established. The charter for the Advisory Council was filed with the
appropriate Congressional committees and the Library of Congress on the
same date. The Advisory Council has been established as a non-
discretionary federal advisory committee.
Objectives and Scope of Activities. The Advisory Council will
provide advice, information, and recommendations to the Secretary
regarding programs and policies intended to support and evaluate the
implementation of Executive Order 13676, including the Strategy and
Action Plan. The Advisory Council will function solely for advisory
purposes.
Membership and Designation. The Advisory Council will consist of
not more than 30 members, including the voting and non-voting members
and Chair and Vice Chair. The members will be appointed or designated
by the Secretary, who will designate the Chair and Vice Chair from
among the voting members of the Advisory Council.
Voting Members. There will be public voting members selected from
individuals who are engaged in research on, or implementation of,
interventions regarding efforts to preserve the effectiveness of
antibiotics by optimizing their use; advance research to develop
improved methods for combating antibiotic resistance and conducting
antibiotic stewardship; strengthen surveillance of antibiotic-resistant
bacterial infections; prevent the transmission of antibiotic-resistant
bacterial infections; advance the development of rapid point-of-care
and agricultural diagnostics; further research on new treatments for
bacterial infections; develop alternatives to antibiotics for
agricultural purposes; maximize the dissemination of up-to-date
information on the appropriate and proper use of antibiotics to the
general public and human and animal healthcare providers; and improve
international coordination of efforts to combat antibiotic resistance.
The public voting members will represent balanced points of view
from human biomedical, public health, and agricultural fields to
include surveillance of antibiotic-resistant infections, prevention
and/or interruptions of the spread of antibiotic-resistant threats, or
development of rapid diagnostics and novel treatments. The public
voting members may be physicians, veterinarians, epidemiologists,
microbiologists, or other health care professionals (e.g., nurses,
pharmacists, others); individuals who have expertise and experience as
consumer or patient advocates concerned with antibiotic resistance, or
in the fields of agriculture and pharmaceuticals; and they also may be
from State or local health agencies or public health organizations. All
public voting members will be classified as special Government
employees (SGEs).
Ex-officio Members (non-voting). The Advisory Council will include
members selected to represent various federal agencies, including HHS,
DoD, and USDA, that are involved in the development, testing,
licensing, production, procurement, distribution, and/or use of
antibiotics and/or antibiotic research. The federal ex-officio members
shall possess the knowledge, skills, experience, and expertise
necessary to generate informed and intelligent recommendations with
respect to the issues mandated by Executive Order 13676. Federal
agencies will be invited to participate as non-voting ex-officio
members of the Advisory Council, as it is deemed necessary by the
Secretary, in consultation with the Secretaries of Defense and
Agriculture, to accomplish the mission the Advisory Council.
Liaison Representatives (non-voting). The Advisory Council
structure also may include non-voting liaison representatives from
organizations and/or interest groups that have involvement in the
development, testing, licensing, production, procurement, distribution,
and/or use of antibiotics and/or antibiotic research. Organizations
will be invited to participate as non-voting liaison representatives as
it is deemed necessary by the Secretary or designee to accomplish the
established mission of the Advisory Council.
The public voting and non-voting liaison representative members
will be appointed to serve for overlapping terms of up to four years.
The Chair and Vice Chair will be appointed to serve for three years,
unless otherwise specified.
The public voting members are authorized to receive per diem and
reimbursement for travel expenses when attending meetings of the
Advisory Council, as authorized by Section 5703, Title 5 U.S.C., as
amended for persons employed intermittently in Government service.
Individuals who are appointed to serve as non-voting liaison
representative members also may be allowed to receive per diem and
reimbursement for any applicable expenses for travel that is performed
to attend meetings of the Advisory Council in accordance with Federal
travel regulations.
Estimated Number and Frequency of Meetings. The Advisory Council
will meet, at a minimum, two times per fiscal year depending on the
availability of funds. Meetings will be open to the public, except as
determined otherwise by the Secretary or other official to whom the
authority has been delegated in accordance with guidelines under
Government in the Sunshine Act, 5 U.S.C. 552b(c).
Nominations: Nominations, including self-nominations, of
individuals who have the specified expertise and knowledge will be
considered for appointment as public voting and/or non-voting members
of the Advisory Council. A nomination should include, at a minimum, the
following for each nominee: (1) A letter of nomination that clearly
states the name and affiliation of the nominee, the basis for the
nomination (i.e., the desired member category and specific attributes
which qualify the nominee to be considered for appointment as a public
voting and/or non-voting member of the Advisory Council), and a
statement from the nominee (including designated representatives of
organizations and/or interest groups) that indicates that the
individual is willing to serve as a member of the Advisory Council, if
selected; (2) the nominator's name, address, and daytime telephone
number, and the address, telephone number, and email address of the
individual being nominated; and (3) a current copy of the nominee's
curriculum vitae or resume, which should be limited to no more than 10
pages.
Every effort will be made to ensure that the Advisory Council is a
diverse group of individuals with representation from various
geographic locations, racial and ethnic minorities, all genders, and
persons living with disabilities.
Individuals being considered for appointment as public voting
members will be required to complete and submit a report of their
financial holdings. An ethics review must be conducted to ensure that
individuals appointed as public voting members of the Advisory Council
are not involved in any activity that may pose a potential conflict of
interest for the official duties that are to be performed. This is a
federal ethics requirement that must be satisfied upon entering the
position and annually throughout the established term of appointment on
the Advisory Council.
[[Page 16686]]
Dated: March 24, 2015.
Sylvia M. Burwell,
Secretary of Health and Human Services.
[FR Doc. 2015-07235 Filed 3-27-15; 8:45 am]
BILLING CODE 4150-28-P
